FASS logotyp
Receptbelagd

Peka på symbolerna och beteckningarna till vänster för en förklaring.

Kontakt

Sök apotek med läkemedlet i lager

Sök lagerstatus

Emtricitabine/Tenofovir disoproxil Sandoz

Sandoz AS

Filmdragerad tablett 200 mg/245 mg
(Blå, kapselformad, filmdragerad tablett, med dimensionerna cirka 19 mm x 9 mm, märkta på ena sidan med “H” och på andra sidan med “E29”.)

Virushämmande medel för systemiskt bruk; virushämmande medel mot hivinfektioner, kombinationer.

Aktiva substanser (i bokstavsordning):
ATC-kod: J05AR03
Läkemedel från Sandoz AS omfattas av Läkemedelsförsäkringen.
  • Vad är miljöinformation?

Miljöinformation

Miljöpåverkan

Miljöinformationen för emtricitabin är framtagen av företaget Janssen för Symtuza

Miljörisk: Användning av emtricitabin har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning: Emtricitabin bryts ned långsamt i miljön.
Bioackumulering: Emtricitabin har låg potential att bioackumuleras.


Läs mer

Detaljerad miljöinformation

Detailed background information

Environmental Risk Classification


Predicted Environmental Concentration (PEC)


PEC is calculated according to the following formula:


PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A*(100-R)


PEC = 0.068337792 µg/L


Where:


A = total actual API sales in Sweden for the most recent year 498.816 kg (total sold amount API in the most recent sales data for Sweden (2022) was distributed by IQVIA in 2023)


R = 0


P = number of inhabitants in Sweden = 10 *106


V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Reference VIII)


D = factor for dilution of wastewater by surface water flow = 10 (ECHA default) (Reference VIII)


Predicted No Effect Concentration (PNEC)


Ecotoxicological studies

Algae (Pseudokirchneriella subcapitata) (guideline e.g. OECD 201) [Reference I]:

EγC50 72 h (yield) > 110 mg/L

NOECγ (yield) ≥ 110 mg/L

ErC50 72 h (growth) > 110 mg/L

NOECr (growth) ≥ 110 mg/L


Crustacean (Daphnia magna) (water-flea) (guideline e.g. OECD 211) [Reference II]:

Acute toxicity

Not available

Chronic toxicity

NOEC 21 days ≥ 110 mg/L (Reproduction)


Fish:

Acute toxicity

No data available


Chronic toxicity


Fish early life stage test with fathead minnow (Pimephales promelas) (guideline e.g. OECD 210) [Reference III]:


NOEC 28 days = 6.10 mg/L (growth, weight)


Other ecotoxicity data:

Activated sludge respiration inhibition test (guideline e.g OECD 209) [Reference IV]


EC50 3h > 1000 mg/L

NOEC 3h ≥ 1000 mg/L


PNEC (µg/l) = lowest NOEC/10, where 10 is the assessment factor used. NOEC for fathead minnow Pimephales promelas of 6.10 mg/L has been used for this calculation since it is the most sensitive of the three tested species.


PNEC = 6.10mg/L/10 = 610 µg/L


Environmental risk classification (PEC/PNEC ratio)

PEC/PNEC = 0.068337792/610 = 0.000112029 i.e. PEC/PNEC ≤ 0,1


The calculated PEC/PNEC ratio is < 0.1.

Use of emtricitabine has been considered to result in insignificant environmental risk.


Degradation

Biotic degradation

Ready degradability:

Emtricitabine was investigated for its ready biodegradation in a 28-day Closed Bottle test according to OECD 301D [Reference V]:

Result: Not readily biodegradable.


Inherent degradability: -

Simulation studies:

Aerobic degradation in aquatic sediment systems


Emtricitabine was investigated for its aerobic degradation in a 100-day aquatic sediment test, according to OECD 308 [Reference VI].


Distribution

Emtricitabine was degraded at a moderate rate under the aerobic water sediment conditions of this study. Emtricitabine decreased from an average of 102.9 and 106.7% of applied radioactivity on day 0 to 66.0 and 14.5% of applied radioactivity at study termination (day 100) for the aerobic Taunton River and Weweantic River sediments, respectively. Percent of applied radioactivity (11.7 and 54.3%, respectively) was converted to 14CO2 in the Taunton River aerobic and Weweantic River aerobic water/sediments (sandy loam and sand), respectively.

Fumigation/extraction biomass results for the aerobic sediments were typical and confirmed a viable microbial population was present over the course of the study.


The whole system DT50 was calculated using single first-order (SFO) kinetics. The primary FTC degradation product was CO2.

Dissipation half life times total system:

Taunton River: DT50 = 150.65 days

Weweantic River: DT50 = 35.91 days


Transformation

Overall mass balance for the transformation of emtricitabine in the aerobic sediment/water systems: the average mass balance ranged from 95.4 to 108.3% of the applied radioactivity for the samples tested over the course of the 100-day study.

Mass Balance (% Applied radioactivity) - [14C]FTC Overall Average & Average Range:

Bild 1

Evolution of 14CO2 reached 11.7% of the applied radioactivity for the Taunton River aerobic test samples and 54.3% of the applied radioactivity for the Weweantic River aerobic test samples by day 100. Negligible quantities of [14C] were detected in the volatile organic compound traps.


Conclusion for degradation:

Emtricitabine is slowly degraded in the total system of the Weweantic River (DT50 = 35.91 days),but is potentially persistent in the total system of the Taunton River (DT50 = 150.65 days). Due to two different degradation phrases the conclusion is that Emtricitabine is slowly degraded in the environment.


Abiotic degradation

Hydrolysis: -

Photolysis: -


Bioaccumulation

Partition coefficient octanol/water:

The partition coefficient octanol/water of emtricitabine was determined according to OECD 107 [Reference VII]


Log Pow = -0.693, -0.670, -0.693 at pH 4, 7 and 10 respectively.


Log Pow = -0.670 at pH 7, so this Log Pow is < 4 at pH 7 which result in following conclusion: Emtricitabine has low potential for bioaccumulation.


Bioconcentration factor (BCF):


No data available


Conclusion for bioaccumulation: Emtricitabine has low potential for bioaccumulation.


Excretion (metabolism)

-

PBT/vPvB assessment

 

PBT-criteria

Results for Emtricitabine

Persistence

Half-life in freshwater: DT50 > 40 days Half-life in sediment: DT50 > 120 days

DT50,system = 35.91- 150.65 days

Bioaccumulation

BCF > 2000

Emtricitabine has low potential for bioaccumulation.

Toxicity

Chronic NOEC < 10 µg/L

NOECalgae ≥ 110 mg/L NOECdaphnia ≥ 110 mg/L NOECfish = 6.10 mg/L

Conclusion for PBT-assessment:

According to the established EU-criteria, emtricitabine should not be regarded as a PBT substance.


References


  1. Acute Toxicity of Emtricitabine to the Freshwater Green Alga Pseudokirchneriella subcapitata Following OECD Guideline 201; Study Report Number TX-162-2002.

  2. Emtricitabine – Full Life-Cycle Toxicity Test with Water Fleas, Daphnia magna, Under Static Renewal Conditions, Following OECD Guideline Number 211; Study Report Number TX-162-2006.

  3. Early Life-Stage Toxicity Test of Emtricitabine with Fathead Minnow (Pimephales promelas), following OECD Guideline 210; Study Report Number TX-162-2005.

  4. Activated Sludge Respiration Inhibition Test to Emtricitabine Following OECD Guideline 209; Study Report Number AD-162-2003.

  5. Emtricitabine: Ready biodegradability Evaluation (OECD 301D); Study 1784.

  6. Emtricitabine – Aerobic and anaerobic Transformation in Aquatic Sediments Systems Following OECD Guideline 308; Study Report Number AD-162-2004.

  7. Determining the Partitioning Coefficient (n-Octanol/Water) of Emtricitabine by the Flask-shaking Method Following OECD Guideline 107; Study Report Number AD-162-2002.

  8. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm

Miljöinformationen för tenofovirdisoproxil är framtagen av företaget MSD för Delstrigo

Miljörisk: Användning av tenofovirdisoproxil har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning: Tenofovirdisoproxil bryts ned i miljön.
Bioackumulering: Tenofovirdisoproxil har låg potential att bioackumuleras.


Läs mer

Detaljerad miljöinformation


Environmental Risk Classification


Predicted Environmental Concentration (PEC)

PEC is calculated according to the following formula:


PEC (μg/L) = (A*109 *(100-R))/(365*P*V*D*100) = 1.37*10-6 *A(100-R)


PEC = 0.07 μg/L


Where:

A = 505 kg (total sold amount API in Sweden year 2021, data from IQVIA) (Ref. I)

R = 0 % removal rate (worst case assumption)

P = number of inhabitants in Sweden = 10 *106 

V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Ref. II)

D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (Ref. II)


Predicted No Effect Concentration (PNEC)


Ecotoxicological studies

Green Algae (Pseudokirchneriella subcapitata) (OECD 201) (Reference III): 

EC50 72h = 69 mg/L (growth rate)

NOEC 72h = 18 mg/L


Crustacean, water flea (Daphnia magna) (OECD 211) (Ref. IV): 

Chronic toxicity

NOEC 21d = 12 mg/L (reproduction)


Fish, fathead minnow (Pimephales promelas) (OECD 210) (Ref. V): 

Chronic toxicity

NOEC 32d = 9 mg/L

No effects noted for any endpoint (hatching, survival, growth)


PNEC = 900 μg/L (9 mg/L/ 10 based on the most sensitive NOEC for the fathead minnow and an assessment factor (AF) of 10)


Environmental risk classification (PEC/PNEC ratio)

PEC/PNEC = 0.07/900 = 7.7E-05, i.e. PEC/PNEC ≤ 0.1 which justifies the phrase "Use of tenofovir disoproxil fumarate has been considered to result in insignificant environmental risk.


Biotic degradation

Biodegradation in Activated Sludge

3.66% to CO2 in 28 days (OECD 314B) (Ref VI)


[14C] Tenofovir DF was evaluated for biodegradability in wastewater according to OECD Guideline 314B. Activated sludge was dosed with approximately 1 mg/L [14C] tenofovir DF. [14C] Tenofovir DF underwent partial primary and ultimate biodegradation over the course of the 28-day study. Mass balance of the biotic sludge system ranged from 94.1 to 100% of the applied radioactivity (% AR). Ultimate biodegradation (conversion to CO2) at 28 days was 3.66% AR in the biotic activated sludge test solution and did not occur in the abiotic activated sludge test solutions. [14C] Tenofovir DF was detected in the biotic sludge at 102% AR on day 0, decreased to 31.6% on day 14, and was not detected through Day 28. One region of radioactivity and a polar region >10% AR were observed in the HPLC analyses of the biotic sludge starting on Day 3. The elimination rate constant, ke, was -0.1628 day-1.


Sediment Transformation (OECD 308) (Ref. VII):

DT50 (total system) = 1.68 – 3.4 days


Aerobic biodegradation of [14C] tenofovir DF was also evaluated in two sediment/water systems at 20°C for 28 days following OECD Guideline 308. Sediment/water systems were dosed with 1 mg/L [14C] tenofovir DF. Carbon dioxide (CO2) produced due to biodegradation was trapped and measured over the test period. Sediment and water samples were extracted and analyzed to determine extractable radioactivity. Water/sediment samples were analyzed at 0, 1, 3, 7, 14, and 28 days of incubation for the Taunton River and Weweantic River test systems. Sediment samples were extracted once with approximately 150 mL of 85/11/4 acetone/purified reagent water/phosphoric acid (v/v/v) and hand shaken to transfer the sediment fraction to a 250-mL Nalgene bottle. The sediment sample was placed on a shaker table at approximately 200 rpm for 10 minutes and then centrifuged at 3000 rpm for 10 minutes. The sediment extract was transferred to a graduated cylinder, the volume recorded, and analyzed by LSC. The extraction procedure was repeated up to two more times for each sampling interval for a total of up to three extractions. The extracts were then combined and analyzed by LSC. The extraction process was terminated after the first extraction for the day 0 sampling interval since >95% AR was recovered from test samples. Day 0 sediment extracts contained <2.5% AR for each sample and therefore, no further analysis was conducted.


The post-extraction solids (PES) were combusted and analyzed by LSC for determination of non-extractable residues. The volatile trapping solutions were analyzed by LSC for determination of 14CO2 and volatile organics. Non-extractable residues in day 28 PES samples were additionally characterized by extraction with a polar and non-polar solvent.


Average recovery ranged from 88.4 to 101% over the course of the study for both the Taunton River and Weweantic River test systems.


The results showed that [14C] tenofovir DF was degraded in total water/sediment systems with an observed half-life of 1.68 and 3.4 days at 20°C in the Taunton and Weweantic Systems, respectively. Corresponding half-lives at 12oC were calculated using the Arrhenius equation and were determined to be 4.74 and 9.09 days (Total System). Half-lives for the water layer were 1.26 days and 3.38 days at 20°C in the Taunton and Weweantic Systems, respectively. Corresponding half-lives at 12°C were calculated using the Arrhenius equation and were determined to be 2.88 and 7.44 days (Water Layer). Half-lives for the sediment extracts were 0.789 days and 5.83 days at 20°C in the Taunton and Weweantic Systems, respectively. Corresponding half-lives at 12°C were calculated using the Arrhenius equation and were determined to be 1.68 and 12.4 days (Sediment Extracts). Tenofovir DF does not undergo significant mineralization and CO2 production during the study ranged from 2.0 to 2.3%.


Evidence of primary biodegradation was observed for [14C] tenofovir DF in the aerobic water/sediment test systems. Three major transformation products (≥10% AR) developed in both the Taunton River and Weweantic River total systems over the course of the study and were designated as polars, TP 2, and TP 4. An additional major transformation product (≥10% AR) developed in the Taunton River total system and was designated as TP 1. These transformation products were identified by LC-MS/MS. Other minor peaks, not exceeding 5.0% AR at more than one interval, were observed in the water layer and sediment extracts and were not characterized further.


Justification of chosen biotic degradation phrase:

Since half-life < 32 days for total system, tenofovir disoproxil fumarate is degraded in the environment.


Bioaccumulation

Partitioning coefficient (OECD 107) (Ref.VIII): 

Log Kow = 1.06 at pH 7


Justification of chosen bioaccumulation phrase:

Since log Kow < 4, tenofovir disoproxil fumarate has low potential for bioaccumulation.


References

  1. Data from IQVIA ”Consumption assessment in kg for input to environmental classification - updated 2022 (data 2021)”.


  2. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment.http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm


  3. Smithers Viscient, 2019. “Tenofovir DF - 72-hour toxicity test with the freshwater green alga, Raphidocelis subcapitata: OECD 201”. Wareham (MA): Smithers Viscient; 25 Mar 2019. 66 p. Smithers Viscient Study No. 359.7085.


  4. Smithers Viscient, 2019. “Tenofovir DF - full life-cycle toxicity test with water fleas, Daphnia magna, under flow-through conditions: OECD 211”. Wareham (MA): Smithers Viscient; 7 Feb 2019. 68 p. Smithers Viscient Study No. 359.7088.


  5. Smithers Viscient, 2019. “Tenofovir DF - early life-stage toxicity test with fathead minnow (Pimephales promelas): OECD 210”. Wareham (MA): Smithers Viscient; 16 Apr 2019. 101 p.Smithers Viscient Study No. 359.7087.


  6. Smithers Viscient, 2019. “[14C]Tenofovir DF - determination of the biodegradability of a test substance in activated sludge based on OECD Method 314B”. Wareham (MA): Smithers Viscient; 19 Mar 2019. 64 p. Smithers Viscient Study No. 359.7082.


  7. Smithers Viscient, 2019. “[14C]Tenofovir DF - aerobic transformation in aquatic sediment systems: OECD 308”. Wareham (MA): Smithers Viscient; 15 Apr 2019. 198 p. Smithers Viscient Study No. 359.7083.


  8. Smithers Viscient, 2019. “Tenofovir DF - determining the partitioning coefficient (n-octanol/water) by the shake-flask method following OECD guideline 107”. Wareham (MA): Smithers Viscient; 21 Jan 2019. 76 p. Smithers Viscient Study No. 359.7080.